News

If your living room window looks out over Circular Quay or leafy Government House, chances are you can’t find a spot to park ...
The FDA has approved Johnson & Johnson's anti-FcRn antibody, nipocalimab, for the treatment of generalized myasthenia gravis. The drug will be sold under the brand name IMAAVY. This approval ...
Pershing Square Holdings, Ltd. ( OTCPK:PSHZF) Q1 2025 Earnings Conference Call May 22, 2025 1:30 PM ET ...